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Endophytic bacteria are organisms that colonize internal plant tissues. These 
organisms are believed to be useful for pharmacological screening and agricultural 
programs for biological control of plant pests and diseases. This project was designed to 
screen endophytic bacteria to be used for pharmaceutical purpose. 
Bacterial endophytes were isolated from the twigs of 50 different healthy tropical 
rain forest plants collected at Kemensal Hill, Ulu Kelang, Selangor. After preparing the 
pure culture of the bacteria, the isolates were subjected to bioassay using disk diffUsion 
method against Bacillus cereus NRRL 1447 (Gram-positive bacteria), Pseudomonas 
aeruginosa ATCC 60690 (Gram-negative bacteria), Bacillus subtilis B28 and B29 
[mutant (deficient in DNA repair) and wild type], Candida lipolytica ATCC 2075 
XIII 
(yeast), Sacchromyces /ipolytica ATCC 16617 (yeast) and Aspergillus ochraceous 
ATCC 398 (fungi). Out of the 79 bacterial endophytes that were isolated from 50 
tropical plants, 12  of them showed antimicrobial activity. One of the isolate (no. 32. 1)  
that possesses the best inhibition activity against target microorganisms was selected for 
further study. By employing biochemical tests, miniaturized multi test system (API 
20NE kit) and whole cellular fatty acid profiles the isolate was identified as 
Pseudomonas aeruginosa UPM strain. 
Judicious combinations of chromatographic techniques were adopted in 
purifying the active compounds from the fermentation media. As a result, two bioactive 
compounds were purified. The structure of these two bioactive compounds were 
elucidated by means of spectroscopic techniques including ultraviolet spectroscopy 
(UV), infrared spectroscopy (IR), nuclear magnetic resonance spectroscopy (IH and 
13C-NMR), mass spectroscopy (MS), also by comparison with the literature and they 
were identified as pyocyanine and I-phenazinole. 
Minimum inhibitory concentration of pyocyanine against P. aeruginosa, B. 
subtilis (B29) and methicillin resistant Staphylococcus auerus was 4.6875 �gldisk, while 
against B. subtilis (B28) and B. cereus was 9.375 Jlgldisk. I-Phenazinole had the MIC 
value of 37.5 Jlgldisk against P. aeruginosa, C. lipolytica, A. ochraceous. The MIC 
value of this compound was 75 and 150 Jlgldisk against B. cereus, B. subtilis (B28 and 
B29), S. lipolytica and MRSA, respectively. Therefore, pyocyanine revealed 
antibacterial activity whereas, I-phenazinole was active against all target microbes. The 
XIV 
antimicrobial activity of I-phenazinole was less than pyocyanine. The cytotoxicity of the 
compounds were tested against the HeLa cells (Human cervical adenocarcinoma), 3T3 
(Mouse fibroblast), T-Lymphoblastic Leukemic cells (CEM-SS) and Sf9 insect cells. 1 -
Phenazinole was found to be more toxic than pyocyanine against the tested cell lines, 
except for CEM-SS. Cytotoxic activity of the compounds against 3T3 cell line (non­
cancerous mouse fibroblast) was lower than against the tumor cell lines. Thus, the 
compounds revealed fairly selective cytotoxic activity against tumor cell lines. The 
compounds showed cytotoxic effect on Sf9 insect cells and therefore could be used for 
biological control. 
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Pengerusi : Prof. Madya Dr. Abdul Manaf Ali 
Fakulti: Sains Makanan dan Bioteknologi 
Bakteria endofitik adalah organisma yang dapat hidup di dalam tisu tumbuhan. 
Organisma-organisma ini dipercayai berguna untuk penyaringan farmakologi serta 
rancangan pertanian disebabkan oleh fungsinya sebagai kawalan biologi untuk haiwan 
perosak tumbuhan dan penyakit. Projek ini dirancang untuk menyaring bakteria 
endofitik bagi tujuan farmaseutikal. 
Bakteria endofitik diisolatkan daripada ranting 50 batang pokok yang berlainan 
dari hutan hujan tropika di Bukit Kemensal, Ulu Kelang, Selangor. Selepas kultur tulen 
bakteria dilakukan, isolat tersebut telah diuji dengan bioasai kaedah penyerapan calera 
terhadap Bacillus cereus NRRL 1447 (bakteria Gram-positif), Pseudomonas aeruJ:,inosa 
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ATCC 60690 (bakteria Gram-negatif), Bacillus subtilis B28 dan B29 [mutan( tidak 
berupaya membaiki DNA) dan jenis liar], Candida lipolytica ATCC 2075 (yis), 
Sacchromyces /ipo/ytica ATCC 16617  (yis) dan Aspergillus ochraceous ATCC 398 
(fungi). Daripada 79 bakteria endofit yang diasingkan, 12 bakteria telah menunjukkan 
aktiviti antimikrob. Salah satu isolat bemombor 32. 1 yang menunjukkan sifat aktiviti 
perencatan terbaik terhadap mikroorganisma sasaran telah dipilih untuk ujian lanjut. 
Dengan penggunaan ujian biokimia, sistem ujian "multi miniaturized"(API 20NE kit) 
serta keseluruhan profil sel asid lemak, isolat tersebut telah dikenalpasti sebagai 
Pseudomonas aeruginosa strain UPM. 
Sebatian-sebatian aktif telah ditulenkan daripada media fermentasi menggunakan 
pelbagai teknik kromatografi. Dua sebatian bioaktif telah ditulen. Kedua-dua struktur 
sebatian aktif ini ditentukan dengan pelbagai teknik spektroskopik termasuk 
spektroskopi ultra ungu (UV), spektroskopi infra-merah (IR), spektroskopi nuklear 
magnetik resonan (lH dan 13C_NMR), spektroskopi jisim (MS) dan perbandingan nilai di 
dalam rujukan dan dikenalpasti sebagai pyocyanine dan I-phenazinole. 
Kepekatan minima bagi perencatan untuk pyocyanine terhadap P. aeruginosa, B. 
subtilis (B29) dan Staphylococcus aureus lentang metisilin (MRSA) adalah 4.6875 
J.1g1disk, manakala bagi B. subtilis (B28) dan B. cereus adalah 9.375 J.1g1disk. 1 -
Phenazinole mencatatkan nilai MIC sebanyak 37 .5  J.1g1disk ke  alas P. aeruginosa, C. 
lipo/ytica, A. ochraceous, manakala nilai MIC sebanyak 75 J.1g1disk terhadap B. cereus, 
B. subtilis (B28 dan B29), S. lipolytica dan 1 50 J.1g1disk terhadap MRSA. Dengan 
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demikian, pyocyanine menunjukkan spektrum aktiviti antibakteria yang luas dan 
sebaliknya I-phenazinole adalah aktif terhadap semua mikrob sasaran. I-Phenazinole 
menunjukkan aktiviti antimikrob yang kurang berbanding dengan pyocyanine. 
Kesitosikan sebatian-sebatian tulen telah diuji terhadap sel HeLa (Human cervical 
adenocarcinoma), sel fibroblas mencit-3T3 (titisan bukan kanser), sel leukemia T­
limfoblastik (CEM-SS) dan sel serangga Sf'). Kesitosikan I-phenazinole adalah lebih 
tinggi berbanding dengan pyocyanine terhadap sel yang diuji kecuali CEM-SS. Aktiviti 
sitotoksik sebatian-sebatian tersebut terhadap sel 3T3 adalah kurang daripada sel kanser. 
Jadi, sebatian-sebatian tersebut telah menunjukkan pemilihan aktiviti sitotoksik terhadap 
sel pertumbuhan. Sebatian-sebatian tersebut juga menunjukkan kesan sitotoksik ke atas 




Antibiotics are chemical substances produced by metabolism of living 
organisms which have inhibitory activity against microorganisms and some other 
animal cells, e.g., tumor cells, or viruses. The principle drugs used in the treatment of 
infectious diseases fall into three categories: antibiotics, sulfonamides, and 
chemotherapeutics (Murray et al., 1995). Collectively, they may be referred to as 
antimicrobics. Antibiotics can be either broad-spectrum antibiotics, active against 
many organisms, or narrow-spectrum antibiotics, active against only a restricted 
range of organisms. 
During World War n, the demand for chemotherapeutic agents to treat 
wound infections led to the development of a production process for penicillin and 
the beginning of the era of antibiotic research. This continues to be the most 
important area of industrial microbiology today. Intensive screening programs in all 
industrial countries continue to increase the number of described antibiotics: 5 1 3  
antibiotics were known in 1961, 407 in 1972, 7650 in 1 985, and currently about 
8000. In addition, about 3000 antibiotically active substances have been detected in 
lichens, algae, higher animals, and plants. Each year, about 300 new antibiotically 
active materials are detected; of which 30-35% are secondary components from 
fermentation with known antibiotics. Approximately 1 0,000 different antibiotics 
have been characterized, but only 123 are currently produced by fermentation (perry 
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and Staley, 1997). In addition, more than 50 antibiotics are produced as 
semisynthetic compounds, and three antibiotics namely, chloramphenicol, 
phosphonomycin, and pyrrolnitrin, are produced completely synthetically (Crueger 
and Crueger 1990). Worldwide antibiotic production is over 100 000 tons per year 
and estimated gross sales for 1980 were US$4.2 billion. The annual gross sales in the 
United State alone are US$lbillion, with cephalosporin in leading position, followed 
by ampicillin and the tetracycline. Feed-additive antibiotics are believed to have a 
world market of US$lOO million annually. Before 1960, about 5% of the newly 
isolated antibiotics were therapeutically useful. In the following years new antibiotics 
were discovered at an approximately constant rate, but the percentage of the new 
antibiotics which actually came on the market decreased from 2.6% in 1961-1965 to 
1% in 1966-1971(Crueger and Crueger 1990). This is primarily because of severe 
cost increase in development and clinical testing, thus those manufacturers produce 
only those compounds that clearly show promising therapeutic progress. About ten 
years are likely to elapse before an agent can be marketed, at an average cost of 
US$10,000,000 to US$20,000,000 (Greengrass, 1997). 
Most antibiotics are produced by bacteria, actinomycetes and fungi but 
compounds may be obtained from many other living organisms such as plants, 
lichens, algae and higher animal organisms (Berdy, 1985). Antibiotic producers can 
be isolated from various natural sources such as soil, water, plants and animals. 
Microorganisms from plants (endophytes) are one of the sources that scarcely have 
been screened for pharmacological purposes but they have a good potential for 
production of antibiotics (Dreyfuss, 1987). 
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Considering the very large number of known compounds, it may seem 
questionable whether the search for new antibiotics should continue. The reasons for 
continued research are: 
• In many cases the properties of natural antibiotics are not optimal for therapeutic 
application. The following improvements are needed: greater activity with 
uncharged or diminished toxicity, decreased side effects, broader antimicrobial 
range, greater selectivity against certain pathogens, improved pharmacological 
properties. 
• Suitable antibiotics are not available in many fields of human medicine or in 
nonmedical areas. Numerous tests have been made of new and semisynthetic 
substances, but no significant breakthroughs have been made. 
• Since the beginning of chemotherapy, the number of resistant strains has 
increased. Multiple- and cross-resistance can occur, i.e., if resistance develops to 
one antibiotic it may simultaneously develop to others having the same mode of 
operation or uptake mechanism. Careless use of antibiotics has been responsible 
for much increase in resistance, but even with careful use in chemotherapy, 
resistance still develops, albeit at a slower rate, Currently, the only alternative for 
overcoming the resistance problem is the discovery of new antibiotics. 
Improved antibiotics can be obtained by modifying known compounds using 
either chemical or genetic means (mutasynthesis, protoplast fusion, and recombinant 
DNA technology). However, antibiotics with entirely new basic structures can be 
expected only from screening, especially by the use of new test procedures and by 
research on new groups of microorganisms. 
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Based on the perspectives presented, the followings were the objectives of this 
study. 
• To isolate bacterial endophytes from tropical rain forest plants. 
• To screen the isolates for antimicrobial activity. 
• To select and identify one isolate with a broad-spectrum of antimicrobial activity. 
• To purify and characterize the antimicrobial metabolites of the isolate. 
CAHPTER II 
LITRERATURE REVIEW 
The History of Antibiotics 
The pre-scientific era of antibiotics has its roots in folk medicine many years 
before Pasteur, Tyndall and others. They recognized the antagonism of 
microorganisms in the last third of 19th century (Florey et al., 1949). The Mayans 
used a fungus known as cuxum for treatment of ulcers and intestinal infections. 
Florey and co-workers (1949) found several references in the medical literature of 
the 19th century on the use of microorganisms for therapeutic purposes. For example, 
Mosse, in 1852, published his experiences in healing wounds with yeast. 
The scientific era in the history of antibiotic can be divided into three periods. 
The first period up to the early 1940s is characterized by the discovery of the first 
known antibiotics, mycophenolic acid, and later by the discovery, isolation and 
therapeutic use of penicillin. Florey and co-workers (1949) reported that the first 
antibiotic isolated in the 1896 by Gosio was from mouldy maize. From such mouldy 
maize, Gosio isolated a fungus, which he named Penicillium glaucvum, but it 
probably is a strain of P. brevi-copactum. After the cultivation of this fungus, Gosio 
was able to isolate a small amount of a crystalline substance from the cultivation 
medium. He found that this substance was phenolic and tested its antibacterial 
effects. The substance inhibited the growth of Bacillus anthracis. 
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In 1913, Alberg and Black isolated a phenolic substance from a Penicillium 
of the same kind of culture. According to its color reaction, they believed that the 
substance was identical with that of Gosio and named it mycophenolic acid. In 1928, 
Fleming discovered an antibacterial agent, produced by a Penicillium contaminating 
an agar plate culture of staphylococci. During observations on staphylococcal 
colonies, he noticed that some of them, growing in the neighborhood of the 
contaminating fungus, became apparently lysed. He picked the contaminating 
penicillium up, grew it on the surface of nutrient broth and found that an antibacterial 
substance was secreted into the medium. This broth was found to contain penicillin. 
The systematic screening of actinomycetes and discoveries of the 
fundamental types of antibiotics characterized the second period. In the 1940s, 
systematic screening programs began in the search for actinomycetes capable of 
producing antibiotics. The first screening surveys made in W aksman' s laboratory and 
elsewhere, established that nearly 50% of all cultures isolated from soil (mostly 
Streptomyces species) were active mainly against Gram-negative bacteria. Apart 
from actinomycetin, actinomycin was the first antibiotic isolated from a culture of an 
actinomycete (Waksman and Woodruff, 1941). Closely related substances were later 
isolated throughout the world and tens of actinomycins are known at present. 
Another antibiotic, proactinomycin was later separated into several components. 
Streptothricin was isolated in the same year (Waksman and Woodruff, 1942). In 
September 1943, the work of Waksman's group culminated in the isolation of 
streptomycin from Streptomyces griseus (Schatz et al., 1944). Streptomycin started a 
great number of studies on the production of antibiotics by actinomycetes. In 1945, 
research on Streptomyces aureojaciens produced an antibiotic, aureomycin (known 
